• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Cigna acquiring Great American Supplemental Benefits

Article

Great American Supplemental Benefits Group, one of the largest manufacturers, distributors, and marketers of supplemental health insurance products in the United States, is being acquired by Cigna Corporation for around $295 million in cash

Great American Supplemental Benefits Group, one of the largest manufacturers, distributors, and marketers of supplemental health insurance products in the United States, is being acquired by Cigna Corporation for around $295 million in cash.

In a press statement, Cigna cited the ability to expand its U.S. presence in individual and Medicare segments as a primary reason for the acquisition. It will also allow the company to extend its direct-to-consumer retail channel and distribution network.

Reuters reports that the group’s current owner, American Financial, expects an after-tax gain of $95 million to $105 million from the sale.

The transaction is expected to close during the second half of 2012.

Go back to the Managed Healthcare Executive eNews newsletter.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.